Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1905, abbreviated as LINC01905, is a member of the long intergenic non-coding RNA (lincRNA) family. LincRNAs are typically defined as non-protein-coding transcripts longer than 200 nucleotides that do not overlap with annotated protein-coding genes[3][5]. They share many properties with other long non-coding RNAs (lncRNAs), including roles in chromatin remodeling, transcriptional regulation, and fine-tuning of gene expression, often through nuclear localization and interacting with chromatin or regulatory complexes[3][5][7]. The biological function of LINC01905 specifically remains uncharacterized; no protein or peptide product has been annotated[1], and it does not currently serve as a known therapeutic target or biomarker. LincRNAs as a class have emerging importance in human disease, notably in cancer and development, but specific information about LINC01905’s disease relevance, interacting drugs, or safety concerns has not yet been established in the literature or major biomedical databases[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1905 (LINC01905).